Kirikou's grandfather thinks that the story of Kirikou and The Witch was too short, so he proceeds to explain more about Kirikou's accomplishments. We find out how the little boy became a gardener, a detective, a maker of pottery, a merchant, a traveler and a doctor.
The grandfather welcomes us into his blue grotto, there was still beautiful memories of childhood to tell Kirikou: the times when he helped the men and women of his village and elsewhere ... He tells us how Kirikou, thanks to his bravery and intelligence, came to the aid of the strong woman. He tells us by what trick the little hero found the grumpy old man, who had been lost in the bush, and how a cherry threatened by the witch was finally able to pass on his knowledge to the villagers. We also discover the secret of a mysterious blue monster, and finally through a flute linked to the family of our small and valiant heroes, the magical power of music.
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance. Paying well is one way to lure job seekers in and keep existing talent happy, in biopharma and beyond. And while CEOs often catch the limelight for their multimillion-dollar paychecks, it is every ... Teva’s innovation engine offsets generics slump, leaving one analyst ‘shocked’ by Ajovy’s surge By Fraiser Kansteiner Jul 29, 2026 10:09am Teva Pharmaceuticals Earnings Ajovy An Adderall shortage that kicked off with Teva Pharmace | Alongside Teva, Amneal Pharmaceutical, Purdue subsidiary Rhodes Pharmaceuticals and Novartis’ soon-to-be-spun-off generics unit Sandoz ... For more than a year, the biopharma industry has had to swiftly react to various tariff threats from the Trump administration. | The president has rolled out a 100% tariff rate on patented ... The industry is entering “the golden era for biosimilars,” Amneal co-CEO Chirag Patel said Wednesday morning as he explained the motivation for his company’s $1.1 billion acquisition of ... For a company founded more than 30 years ago, Vertex Pharmaceuticals—in its current iteration—came into being after a prescient R&D strategy decision from its top brass about a decade ago. Explore Fierce Pharma's comprehensive resources on the pharmaceutical industry, including insights, strategies, and innovations for professionals. About a year and a half after telegraphing plans to shift its headquarters from New Jersey to Philadelphia, CDMO Adare Pharma Solutions appears to be turning out the lights at another facility in ... After a flurry of Big Pharma deals in the first week of the new year, the life sciences industry is heading to San Francisco for the industry's big | After a flurry of Big Pharma deals in the ...
![[.Pelis.]](https://pelis.flixshore.com/wp-content/uploads/2026/03/camera.png)
